<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BICC1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>BICC1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9H694" target="_blank" class="term-link">
                        Q9H694
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-in-progress">
                    IN PROGRESS
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "BICC1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9H694" data-a="DESCRIPTION: BICC1 (BicC family RNA-binding protein 1) encodes ..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>BICC1 (BicC family RNA-binding protein 1) encodes an evolutionarily conserved RNA-binding protein that functions as a post-transcriptional regulator of gene expression. The protein contains three N-terminal KH (K Homology) domains that mediate RNA binding, and a C-terminal SAM (sterile alpha motif) domain that enables self-polymerization and protein-protein interactions. BICC1 acts primarily as a translational repressor, binding specific mRNA 3&#39;UTRs and recruiting the CCR4-NOT deadenylase complex or microRNA machinery to silence target transcripts. Key functions include negative regulation of the canonical Wnt signaling pathway and modulation of cAMP signaling through regulation of target mRNAs such as PKD2, ADCY6, and DVL2. BICC1 localizes to cytoplasmic P-bodies where it forms oligomeric silencing platforms. Loss of BICC1 function causes polycystic kidney disease in mice and humans, and mutations are associated with cystic renal dysplasia. BICC1 is also involved in left-right axis determination during embryonic development.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0005737" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 is well-established as a cytoplasmic protein. Studies show that endogenous BICC1 concentrates in discrete cytoplasmic foci that co-localize with P-body markers (GW182, HEDLS). The SAM domain drives self-polymerization leading to formation of cytoplasmic puncta (Rothe et al. 2015, PMC4561730).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Strongly supported by multiple studies demonstrating BICC1 localizes to cytoplasmic P-bodies where it forms silencing platforms for mRNA regulation. UniProt also indicates cytoplasmic localization by similarity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">BICC1 carries out its function in the cytoplasm, where it associates with macromolecular RNA-protein granules. Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that co-localize with P-body markers (e.g. GW182 and HEDLS).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003676" target="_blank" class="term-link">
                                    GO:0003676
                                </a>
                            </span>
                            <span class="term-label">nucleic acid binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0003676" data-r="GO_REF:0000002" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is too general. BICC1 specifically binds RNA, not DNA. The protein contains three KH domains that are classic RNA-binding motifs, and studies have identified specific RNA targets including a 32-nucleotide stem-loop structure in target mRNA 3&#39;UTRs (Zhang et al. 2014, PMC3953263).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically not wrong (RNA is a nucleic acid), this term is overly broad and does not capture the specific RNA-binding function of BICC1. The more specific term GO:0003723 (RNA binding) should be used.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003723" target="_blank" class="term-link">
                                    RNA binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">BICC1&#39;s three KH domains enable it to bind RNA with sequence/structure specificity. Canonical KH domains recognize short nucleotide motifs, often polypyrimidine tracts, but in BICC1 the recognition appears to involve RNA secondary structure.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003723" target="_blank" class="term-link">
                                    GO:0003723
                                </a>
                            </span>
                            <span class="term-label">RNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0003723" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 is definitively an RNA-binding protein. It contains three KH domains that mediate RNA binding. Multiple studies have demonstrated direct RNA binding including identification of a 32-nt stem-loop binding element in the Cripto-1 3&#39;UTR (Zhang et al. 2014). RIP-seq in Xenopus identified 63 direct mRNA targets.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core molecular function supported by extensive experimental evidence including biochemical studies (EMSA, RNase footprinting) and proteomics (interactome capture). The KH domains are well-characterized RNA-binding motifs.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Biochemical analyses (EMSA and footprinting) confirm that BICC1&#39;s N-terminal half (containing the KH/KHL domains) directly binds RNA hairpins - for instance, BICC1 protects the Cripto-1 3&#39;UTR stem-loop from RNase cleavage, highlighting a direct RNA-protein interaction.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0005737" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation of cytoplasmic localization. This IEA annotation based on UniProt subcellular location is consistent with the IBA annotation and experimental evidence showing BICC1 in cytoplasmic P-bodies.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasmic localization is well-supported. While this duplicates the IBA annotation, both are accurate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">BICC1 carries out its function in the cytoplasm, where it associates with macromolecular RNA-protein granules.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006402" target="_blank" class="term-link">
                                    GO:0006402
                                </a>
                            </span>
                            <span class="term-label">mRNA catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0006402" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 participates in mRNA catabolism through recruitment of the CCR4-NOT deadenylase complex. In Drosophila, Bic-C physically associates with CCR4-NOT to deadenylate bound transcripts. This promotes mRNA poly(A) tail shortening which can lead to mRNA degradation (Rothe et al. 2015, PMC4561730).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> BICC1 recruits mRNA decay machinery to target transcripts. The CCR4-NOT deadenylase association is established and deadenylation is a key step in mRNA catabolism. However, note that BICC1&#39;s primary role may be translational repression rather than degradation per se.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Drosophila Bic-C physically associates with the CCR4-NOT deadenylase complex to deadenylate bound transcripts (including its own mRNA), indicating that BICC1 can induce mRNA poly(A) tail shortening to inhibit translation.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006402" target="_blank" class="term-link">
                                    GO:0006402
                                </a>
                            </span>
                            <span class="term-label">mRNA catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0006402" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation of mRNA catabolic process. The ISS annotation from ortholog transfer is consistent with the IEA annotation and mechanistic evidence of CCR4-NOT deadenylase recruitment.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Supported by evidence of BICC1 recruiting deadenylase machinery, though primary role is likely translational silencing with catabolism as a secondary outcome.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">BICC1 can recruit mRNA decay and translational inhibition machinery.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007368" target="_blank" class="term-link">
                                    GO:0007368
                                </a>
                            </span>
                            <span class="term-label">determination of left/right symmetry</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0007368" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 is involved in left-right axis determination during embryonic development. Mouse Bicc1 knockout mutants exhibit visceral organs with random laterality due to disrupted embryonic node signaling. BICC1 binds and regulates Dand5 mRNA, an inhibitor of Nodal signaling crucial for left-right asymmetry (Rothe et al. 2015, PMC4561730; Dowdle et al. 2022).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Well-supported by mouse knockout studies showing left-right patterning defects and identification of Dand5 as a BICC1 target mRNA critical for establishing asymmetry at the embryonic node.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Mouse Bicc1 knockout or spontaneous mutants (such as jcpk and bpk alleles) exhibit left-right patterning defects - the visceral organs show random laterality due to disrupted embryonic node signaling. This is attributed to misregulation of molecular cues at the embryonic node, where BICC1 is needed for planar cell polarity and proper orientation of motile cilia. Indeed, Bicc1 was recently shown to bind and regulate the mRNA of Dand5 (an inhibitor of Nodal signaling crucial for left-right asymmetry), linking BICC1 to left-right axis specification.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003723" target="_blank" class="term-link">
                                    GO:0003723
                                </a>
                            </span>
                            <span class="term-label">RNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22658674" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22658674
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Insights into RNA biology from an atlas of mammalian mRNA-bi...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0003723" data-r="PMID:22658674" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 was identified as an mRNA-binding protein in the mRNA interactome capture study by Castello et al. 2012. This high-throughput UV crosslinking approach identified BICC1 among 860 proteins that qualify as RBPs by biochemical and statistical criteria in HeLa cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The interactome capture methodology provides robust biochemical evidence for RNA binding. This complements the detailed mechanistic studies showing KH domain-mediated RNA binding.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22658674" target="_blank" class="term-link">
                                        PMID:22658674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We identify 860 proteins that qualify as RBPs by biochemical and statistical criteria, adding more than 300 RBPs to those previously known and shedding light on RBPs in disease, RNA-binding enzymes of intermediary metabolism, RNA-binding kinases, and RNA-binding architectures.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0090090" target="_blank" class="term-link">
                                    GO:0090090
                                </a>
                            </span>
                            <span class="term-label">negative regulation of canonical Wnt signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21922595" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21922595
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Two mutations in human BICC1 resulting in Wnt pathway hypera...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0090090" data-r="PMID:21922595" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 acts as a negative regulator of canonical Wnt signaling. Kraus et al. 2012 demonstrated that human BICC1 blocks canonical Wnt signaling, similar to its mouse counterpart. Two patient mutations were characterized - a nonsense mutation in the KH domain caused complete loss of Wnt inhibitory activity, while a SAM domain mutation reduced activity by 22%. BICC1 inhibits Dishevelled-2 (DVL2), a central Wnt signal transducer (Rothe et al. 2015, PMC4561730).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function supported by direct experimental evidence in the cited paper. The mechanistic basis involves regulation of Dvl2 and potentially other Wnt pathway components. Loss of BICC1 causes ectopic Wnt/beta-catenin activity during development.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21922595" target="_blank" class="term-link">
                                        PMID:21922595
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In mice, Bicc1 blocks canonical Wnt signaling, mostly via its SAM domain. We show that the human BICC1, similar to its mouse counterpart, blocks canonical Wnt signaling. The nonsense mutation identified results in a complete loss of Wnt inhibitory activity. The point mutation in the SAM domain has a similar effect to a complete SAM domain deletion, resulting in a 22% loss of activity.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">A study by Rothe et al. (2015) showed that BICC1 normally inhibits Dishevelled-2 (DVL2), a central Wnt signal transducer: BICC1 binds the Dvl2 mRNA or interacts with DVL2 protein complexes, and when BICC1 polymerization is disrupted, DVL2 levels and Wnt activity rise abnormally.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000956" target="_blank" class="term-link">
                                    GO:0000956
                                </a>
                            </span>
                            <span class="term-label">nuclear-transcribed mRNA catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0000956" data-r="GO_REF:0000033" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Proposed new annotation based on BICC1&#39;s role in mRNA regulation. BICC1 recruits the CCR4-NOT deadenylase complex to target mRNAs, promoting their deadenylation and subsequent degradation. This specifically applies to nuclear-transcribed mRNAs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GO:0006402 (mRNA catabolic process) is already annotated, the more specific term for nuclear-transcribed mRNA catabolism may be appropriate given BICC1&#39;s targets are conventional mRNAs.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Drosophila Bic-C physically associates with the CCR4-NOT deadenylase complex to deadenylate bound transcripts.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0017148" target="_blank" class="term-link">
                                    GO:0017148
                                </a>
                            </span>
                            <span class="term-label">negative regulation of translation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0017148" data-r="GO_REF:0000033" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 functions as a translational repressor. It binds target mRNA 3&#39;UTRs and typically represses their translation through multiple mechanisms including deadenylation and recruitment of microRNA machinery. Validated targets include Cripto-1, Pkd2, and Wnt11b mRNAs (Zhang et al. 2014, PMC3953263; Dowdle et al. 2022).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This represents a core molecular function of BICC1 that is well-documented but not currently annotated. BICC1 acts as a translational repressor by binding 3&#39;UTRs and forming silencing complexes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">BICC1 primarily acts as a post-transcriptional regulator of gene expression. It recognizes specific RNA sequences/structures in the 3&#39; untranslated regions (3&#39;UTRs) of target mRNAs and typically represses their translation or reduces their stability.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0036464" target="_blank" class="term-link">
                                    GO:0036464
                                </a>
                            </span>
                            <span class="term-label">cytoplasmic ribonucleoprotein granule</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0036464" data-r="GO_REF:0000033" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BICC1 localizes to cytoplasmic P-bodies, which are ribonucleoprotein granules involved in mRNA storage, decay, and microRNA-mediated silencing. The SAM domain drives oligomerization and formation of these cytoplasmic puncta (Rothe et al. 2015, PMC4561730).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> More specific cellular component than general cytoplasm. BICC1 specifically concentrates in P-bodies where it forms silencing platforms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites of mRNA storage, decay, and microRNA-mediated silencing, suggesting BICC1 functions within these structures to tether and regulate target mRNAs.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000932" target="_blank" class="term-link">
                                    GO:0000932
                                </a>
                            </span>
                            <span class="term-label">P-body</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9H694" data-a="GO:0000932" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BICC1/BICC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites of mRNA storage, decay, and microRNA-mediated silencing.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>BICC1 functions as an RNA-binding translational repressor. It contains three KH domains that bind specific stem-loop structures in target mRNA 3&#39;UTRs, including Cripto-1, Pkd2, Dvl2, Wnt11b, and Dand5. BICC1 recruits the CCR4-NOT deadenylase complex to silence target transcripts. The SAM domain mediates self-polymerization and localization to cytoplasmic P-bodies where BICC1 forms oligomeric silencing platforms. Through regulation of Dvl2 and other Wnt pathway components, BICC1 negatively regulates canonical Wnt signaling. Evidence includes mRNA interactome capture (PMID:22658674), functional studies showing Wnt pathway regulation (PMID:21922595), and biochemical characterization of RNA binding (Zhang et al. 2014, PMC3953263).</h3>
                <span class="vote-buttons" data-g="Q9H694" data-a="FUNCTION: BICC1 functions as an RNA-binding translational re..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003723" target="_blank" class="term-link">
                            RNA binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0017148" target="_blank" class="term-link">
                                negative regulation of translation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0090090" target="_blank" class="term-link">
                                negative regulation of canonical Wnt signaling pathway
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000932" target="_blank" class="term-link">
                                P-body
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/BICC1/BICC1-deep-research-openai.md
                            
                        </span>
                        
                        <div class="finding-text">Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites of mRNA storage, decay, and microRNA-mediated silencing.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000024.md" target="_blank" class="term-link">
                            GO_REF:0000024
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21922595" target="_blank" class="term-link">
                            PMID:21922595
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Human BICC1 blocks canonical Wnt signaling similar to mouse counterpart. Mutations in KH domain cause complete loss of Wnt inhibitory activity, while SAM domain mutations reduce activity by 22%.</div>
                        
                        <div class="finding-text">"In mice, Bicc1 blocks canonical Wnt signaling, mostly via its SAM domain. We show that the human BICC1, similar to its mouse counterpart, blocks canonical Wnt signaling. The nonsense mutation identified results in a complete loss of Wnt inhibitory activity. The point mutation in the SAM domain has a similar effect to a complete SAM domain deletion, resulting in a 22% loss of activity."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22658674" target="_blank" class="term-link">
                            PMID:22658674
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">BICC1 identified as RNA-binding protein through interactome capture in HeLa cells using UV crosslinking methodology.</div>
                        
                        <div class="finding-text">"We identify 860 proteins that qualify as RBPs by biochemical and statistical criteria, adding more than 300 RBPs to those previously known and shedding light on RBPs in disease, RNA-binding enzymes of intermediary metabolism, RNA-binding kinases, and RNA-binding architectures."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/BICC1/BICC1-deep-research-openai.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on BICC1 gene function (OpenAI o3-deep-research, January 2026)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">BICC1 is an RNA-binding protein that acts as a translational repressor, binding specific mRNA 3&#39;UTRs via KH domains and recruiting silencing machinery including the CCR4-NOT deadenylase complex.</div>
                        
                        <div class="finding-text">"BICC1 primarily acts as a post-transcriptional regulator of gene expression. It recognizes specific RNA sequences/structures in the 3&#39; untranslated regions (3&#39;UTRs) of target mRNAs and typically represses their translation or reduces their stability."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">BICC1 localizes to cytoplasmic P-bodies where it forms oligomeric silencing platforms through SAM domain-mediated self-polymerization.</div>
                        
                        <div class="finding-text">"Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites of mRNA storage, decay, and microRNA-mediated silencing."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">BICC1 negatively regulates canonical Wnt signaling by inhibiting Dishevelled-2 (DVL2). Loss of BICC1 causes ectopic Wnt/beta-catenin activity during embryonic development.</div>
                        
                        <div class="finding-text">"A study by Rothe et al. (2015) showed that BICC1 normally inhibits Dishevelled-2 (DVL2), a central Wnt signal transducer: BICC1 binds the Dvl2 mRNA or interacts with DVL2 protein complexes, and when BICC1 polymerization is disrupted, DVL2 levels and Wnt activity rise abnormally."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">BICC1 is essential for kidney development and homeostasis. Loss of BICC1 causes polycystic kidney disease in mice and humans through dysregulation of PKD2 and cAMP signaling.</div>
                        
                        <div class="finding-text">"BICC1 safeguards kidney tubule morphology by regulating specific mRNAs tied to epithelial differentiation and signaling. A key target is PKD2 (Polycystin-2), a Ca2+-permeable channel essential for renal tubule integrity. Wessely and colleagues (2010) discovered that BICC1 binds to and stabilizes Pkd2 mRNA, enhancing Polycystin-2 expression."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Mouse Bicc1 knockout mutants exhibit left-right patterning defects due to misregulation of Dand5 mRNA at the embryonic node.</div>
                        
                        <div class="finding-text">"Mouse Bicc1 knockout or spontaneous mutants (such as jcpk and bpk alleles) exhibit left-right patterning defects - the visceral organs show random laterality due to disrupted embryonic node signaling."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(BICC1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9H694" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2026-01-15T19:32:29.416869'<br />
end_time: '2026-01-15T19:41:15.499736'<br />
duration_seconds: 526.08<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: BICC1<br />
  gene_symbol: BICC1<br />
  uniprot_accession: Q9H694<br />
  protein_description: 'RecName: Full=Protein bicaudal C homolog 1; Short=Bic-C;'<br />
  gene_info: Name=BICC1;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the BicC family. .<br />
  protein_domains: BICC1_KH. (IPR054727); BICC1_KH-I_rpt1. (IPR047549); BICC1_KH-I_rpt2.<br />
    (IPR047554); BICC1_KH-I_rpt3. (IPR047553); BICC1_SAM_dom. (IPR037974)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 174</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9H694</li>
<li><strong>Protein Description:</strong> RecName: Full=Protein bicaudal C homolog 1; Short=Bic-C;</li>
<li><strong>Gene Information:</strong> Name=BICC1;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the BicC family. .</li>
<li><strong>Key Domains:</strong> BICC1_KH. (IPR054727); BICC1_KH-I_rpt1. (IPR047549); BICC1_KH-I_rpt2. (IPR047554); BICC1_KH-I_rpt3. (IPR047553); BICC1_SAM_dom. (IPR037974)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "BICC1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'BICC1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>BICC1</strong> (gene ID: BICC1, UniProt: Q9H694) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="overview-and-key-concepts">Overview and Key Concepts</h1>
<p><strong>BICC1 (BicC family RNA-binding protein 1)</strong> is a human gene encoding the <strong>protein bicaudal-C homolog 1</strong>, an evolutionarily conserved RNA-binding protein involved in post-transcriptional gene regulation (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental">www.frontiersin.org</a>). BICC1 was first identified in <em>Drosophila</em> as the gene mutated in <em>bicaudal</em> fly mutants, which develop mirror-duplicated posterior structures (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental">www.frontiersin.org</a>). The human BICC1 protein contains three N-terminal <strong>K Homology (KH) domains</strong> ‚Äì classic RNA-binding motifs ‚Äì and a C-terminal <strong>sterile Œ±-motif (SAM)</strong> domain (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,protein">www.frontiersin.org</a>). The KH domains (and adjacent KH-like regions) mediate specific binding to target mRNAs, whereas the SAM domain mediates protein‚Äìprotein interactions and self-oligomerization (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,Sequence%20conservation%20among%20vertebrates">www.frontiersin.org</a>). These conserved domains underlie BICC1‚Äôs role as a <strong>translational repressor</strong> that binds particular mRNA transcripts and controls their stability and translation in numerous biological contexts (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,metabolism%20functions%20in%20vertebrate%20embryos">www.frontiersin.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Molecular Function:</strong> BICC1 primarily acts as a post-transcriptional regulator of gene expression. It recognizes specific RNA sequences/structures in the 3‚Ä≤ untranslated regions (3‚Ä≤UTRs) of target mRNAs and typically <strong>represses their translation</strong> or reduces their stability (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288">pmc.ncbi.nlm.nih.gov</a>). Notably, BICC1 was shown to bind a defined 32-nucleotide <strong>stem‚Äìloop structure</strong> in the 3‚Ä≤UTR of <em>Xenopus</em> <em>Cripto-1</em> (an embryonic signaling factor) ‚Äì this minimal RNA element is sufficient for BICC1 binding and translational repression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward">pmc.ncbi.nlm.nih.gov</a>). This finding (Sheets <em>et al.</em>, <em>J. Biol. Chem.</em>, 2014) was the first to identify a specific <strong>Bicc1-binding RNA motif</strong>, suggesting BICC1 targets share common structural features (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward">pmc.ncbi.nlm.nih.gov</a>). Consistent with an RNA silencing role, BICC1 can recruit mRNA decay and translational inhibition machinery: <strong>Drosophila</strong> Bic-C physically associates with the CCR4-NOT deadenylase complex to deadenylate bound transcripts (including its own mRNA) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=sequence%20%28see%20Fig,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=,16">pmc.ncbi.nlm.nih.gov</a>), indicating that BICC1 can induce mRNA <strong>poly(A)</strong> tail shortening to inhibit translation.</p>
<p><strong>Subcellular Localization:</strong> BICC1 carries out its function in the <strong>cytoplasm</strong>, where it associates with macromolecular RNA‚Äìprotein granules. Endogenous BICC1 protein concentrates in discrete <strong>cytoplasmic foci</strong> that co-localize with P-body markers (e.g. GW182 and HEDLS) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism">pmc.ncbi.nlm.nih.gov</a>). P-bodies are sites of mRNA storage, decay, and microRNA-mediated silencing, suggesting BICC1 functions within these structures to tether and regulate target mRNAs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism">pmc.ncbi.nlm.nih.gov</a>). The SAM domain is critical for this localization: it <strong>self-polymerizes</strong> and drives BICC1 oligomerization, leading to formation of BICC1 puncta in cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Bicc1%20is%20localized%20in%20cytoplasmic,42">pmc.ncbi.nlm.nih.gov</a>). In vitro, the isolated human BICC1 SAM domain can assemble into a helical polymer (observed by electron microscopy) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Bicc1%20is%20localized%20in%20cytoplasmic,42">pmc.ncbi.nlm.nih.gov</a>). <strong>Polymerization</strong> of BICC1 via SAM is functionally important ‚Äì it increases BICC1‚Äôs local concentration and forms a silencing platform for bound mRNAs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=including%20adenylate%20cyclase%206%20%28AC6%29,catenin">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=then%20mutated%20the%20SAM%20domain,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>). Mutations that disrupt SAM‚ÄìSAM interaction prevent BICC1 clustering and impair its ability to repress target mRNA expression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=polymerizes%20in%20vitro%20and%20localizes,conclude%20that%20polymerization%20is%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=polymerize%20Bicc1%20in%20a%20left,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>). For example, engineered BICC1 mutants with a defective SAM interface show diffuse cytosolic distribution and fail to efficiently silence a reporter mRNA, underscoring that <strong>multimerization is required for full repressive activity</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=then%20mutated%20the%20SAM%20domain,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>). Polymerization also stabilizes the BICC1 protein itself: oligomerization-deficient BICC1 is more rapidly degraded, reducing its steady-state levels (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,stabilize%20Bicc1%20and%20to%20present">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>KH Domains and RNA Binding:</strong> BICC1‚Äôs three KH domains enable it to bind RNA with sequence/structure specificity. Canonical KH domains recognize short nucleotide motifs, often polypyrimidine tracts, but in BICC1 the recognition appears to involve RNA secondary structure (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=mRNA%20features%20required%20for%20Bicaudal,binding">www.frontiersin.org</a>). In <em>Xenopus</em>, the Bicc1 protein (also called Bic-C) was found to selectively bind <strong>63 mRNA targets</strong> in early embryos (identified by RIP-seq) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,41%20Maerker%20et%20al">www.frontiersin.org</a>). Validated targets include <em>cripto1</em> and <em>dand5</em> (key regulators of Nodal/TGF-Œ≤ signaling), <em>wnt11b</em> (a Wnt ligand), and <em>gdf3</em> (a TGF-Œ≤ family factor) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=targets,development%20and%20potentially%20other%20contexts">www.frontiersin.org</a>). These mRNAs share Bicc1-dependent repression via their 3‚Ä≤UTRs, and many contain predicted stem‚Äìloop elements, consistent with BICC1‚Äôs binding preferences (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a">www.frontiersin.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=This%2032,control%20cellular%20function%20in%20metazoans">pmc.ncbi.nlm.nih.gov</a>). Biochemical analyses (EMSA and footprinting) confirm that BICC1‚Äôs N-terminal half (containing the KH/KHL domains) directly binds RNA hairpins ‚Äì for instance, BICC1 protects the <em>Cripto-1</em> 3‚Ä≤UTR stem-loop from RNase cleavage, highlighting a direct RNA‚Äìprotein interaction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Here%2C%20we%20used%20EMSA%2C%20RNase,mediated%20translational%20repression%20in%20vivo">pmc.ncbi.nlm.nih.gov</a>). Thus, <strong>BICC1 acts by physically binding target mRNA 3‚Ä≤UTRs</strong> via its KH domains and forming repressive mRNP complexes.</p>
<h1 id="biological-roles-and-mechanisms">Biological Roles and Mechanisms</h1>
<h2 id="developmental-and-cellular-functions">Developmental and Cellular Functions</h2>
<p><strong>Embryonic Development:</strong> BICC1 is crucial for proper embryonic patterning and cell-fate decisions. Originally discovered through its role in fly oogenesis, Bicaudal-C was shown to repress translation of <em>oskar</em> mRNA at the anterior of the oocyte ‚Äì <em>Bic-C</em> mutants had ectopic Oskar protein, causing anterior abdomen duplication (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=RNA,C%20has%20been%20shown%20to">pmc.ncbi.nlm.nih.gov</a>). In vertebrates, BICC1 performs analogous functions to spatially regulate developmental signals. <em>Xenopus</em> Bicc1 is a maternal determinant that localizes specific mRNAs to vegetal cells and silences them until the correct stage (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288">pmc.ncbi.nlm.nih.gov</a>). For example, <em>Xenopus</em> Bicc1 restricts <em>Cripto-1</em> translation to the embryo‚Äôs animal pole; without Bicc1, <em>Cripto-1</em> (a co-receptor for Nodal signals) is expressed ectopically in vegetal cells, disrupting germ layer patterning (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288">pmc.ncbi.nlm.nih.gov</a>). In line with these findings, loss of BICC1 function leads to dramatic developmental defects. <strong>Mouse Bicc1</strong> knockout or spontaneous mutants (such as <strong>jcpk</strong> and <strong>bpk</strong> alleles) exhibit <strong>left‚Äìright patterning defects</strong> ‚Äì the visceral organs show random laterality due to disrupted embryonic node signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=match%20at%20L106%20%2831%E2%80%9334%29,Together%2C%20these">pmc.ncbi.nlm.nih.gov</a>). This is attributed to misregulation of molecular cues at the embryonic node, where BICC1 is needed for planar cell polarity and proper orientation of motile cilia (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=match%20at%20L106%20%2831%E2%80%9334%29,Together%2C%20these">pmc.ncbi.nlm.nih.gov</a>). Indeed, Bicc1 was recently shown to bind and regulate the mRNA of <em>Dand5</em> (an inhibitor of Nodal signaling crucial for left-right asymmetry), linking BICC1 to left‚Äìright axis specification (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=%28Mesner%20et%20al,42">www.frontiersin.org</a>).</p>
<p><strong>Molecular Pathways:</strong> BICC1 interfaces with major signaling pathways during development. <strong>Wnt/Œ≤-catenin signaling</strong> is one pathway influenced by BICC1. In mouse embryos, loss of Bicc1 causes <strong>ectopic Wnt/Œ≤-catenin activity</strong> during gastrulation and left‚Äìright patterning (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>). Mechanistically, BICC1 helps restrain Wnt signaling by targeting key components of the pathway. A study by Roth√© <em>et al.</em> (2015) showed that BICC1 normally <strong>inhibits <em>Dishevelled-2</em> (DVL2)</strong>, a central Wnt signal transducer: BICC1 binds the <em>Dvl2</em> mRNA or interacts with DVL2 protein complexes, and when BICC1 polymerization is disrupted, DVL2 levels and Wnt activity rise abnormally (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>). In <em>Xenopus</em>, Bicc1 also binds <em>wnt11b</em> mRNA (encoding a noncanonical Wnt ligand) and the TGF-Œ≤ ligand <em>gdf3</em>, ensuring these signals are produced only at the correct time and place (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=these%20targets%20were%20validated%20using,development%20and%20potentially%20other%20contexts">www.frontiersin.org</a>). <strong>Nodal/TGF-Œ≤ signaling</strong> is another pathway regulated by BICC1 through targets like <em>Cripto-1</em> and <em>Dand5</em>, as noted above. By modulating these pathways, BICC1 has broad effects on <strong>cell fate determination</strong>, anterior‚Äìposterior and dorsal‚Äìventral patterning, and organogenesis in the embryo (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a">www.frontiersin.org</a>).</p>
<p><strong>Protein Family and Evolution:</strong> BICC1 belongs to the <strong>Bic-C family</strong> of RNA-binding proteins, which are found in many metazoans (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,that%20Bicc1%20proteins%20have%20on">www.frontiersin.org</a>). Vertebrates typically have a single BICC1 gene (in contrast, <em>Drosophila</em> has a single <em>Bic-C</em>, and <em>C. elegans</em> has multiple related proteins). The sequence and domain architecture are highly conserved from fruit flies to humans (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,protein">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=KH%20domains%20contain%20GXXG%20motifs,27">www.frontiersin.org</a>). This conservation suggests that insights from model organisms translate to human BICC1‚Äôs function. For instance, the <strong>KH3 domain</strong> and <strong>SAM domain</strong> show especially high conservation, implying they mediate critical interactions (RNA-binding and self-assembly, respectively) that have been maintained through evolution (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,Sequence%20conservation%20among%20vertebrates">www.frontiersin.org</a>). Experimental evidence supports this: human BICC1 can functionally substitute for <em>Xenopus</em> Bicc1 in certain assays (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288">pmc.ncbi.nlm.nih.gov</a>), and many mRNA targets (e.g., <em>Polycystin-2</em>, see below) are regulated by BICC1 across species (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=health%20of%20several%20adult%20tissues,organism%20have%20not%20been%20described">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=their%203%E2%80%B2UTRs%20was%20inhibited%20by,42%20Minegishi%20et%20al">www.frontiersin.org</a>). Thus, BICC1 is a fundamental post-transcriptional regulator, with a role in balancing developmental signaling networks in diverse animals.</p>
<h2 id="role-in-kidney-function-and-cystic-disease">Role in Kidney Function and Cystic Disease</h2>
<p>One of the most prominent roles of BICC1 in mammals is in <strong>kidney development and homeostasis</strong>. Multiple lines of evidence demonstrate that BICC1 is required for maintaining normal kidney architecture (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Multiple%20lines%20of%20evidence%20have,of%20mouse%20Bicc1%20as%20well">www.frontiersin.org</a>). Mice with inactivated <em>Bicc1</em> display severe <strong>polycystic kidney disease (PKD)-like phenotypes</strong>: their kidneys are enlarged and full of fluid-filled cysts formed from dilated renal tubules (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=mutants%20are%20characterized%20by%20the,17">pmc.ncbi.nlm.nih.gov</a>). These cystic kidneys closely resemble human autosomal polycystic kidney disease, indicating BICC1 is a crucial cyst suppressor in vertebrates (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=mutants%20are%20characterized%20by%20the,17">pmc.ncbi.nlm.nih.gov</a>). Indeed, <em>BICC1</em> mutations in humans have been linked to renal cystic dysplasia. <strong>Kraus <em>et al. (2012</em></strong>, <em>Human Mutation</em>) reported two human families where recessive <em>BICC1</em> loss-of-function mutations led to congenital cystic kidney disease; patient tissues showed inappropriate activation of Wnt signaling, consistent with the mouse model (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed">pmc.ncbi.nlm.nih.gov</a>). More recently (2022), <em>BICC1</em> variants have been identified by exome sequencing in fetuses with severe <strong>cystic kidney malformations</strong> (multicystic dysplastic kidneys), further supporting its clinical relevance in kidney development (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=organisms%20mutations%20of%20mouse%20Bicc1,embryos%20result%20in%20cystic%20kidneys">www.frontiersin.org</a>).</p>
<p><strong>Molecular function in kidney:</strong> BICC1 safeguards kidney tubule morphology by regulating specific mRNAs tied to epithelial differentiation and signaling. A key target is <strong>PKD2 (Polycystin-2)</strong>, a Ca¬≤‚Å∫-permeable channel essential for renal tubule integrity. Wessely and colleagues (2010, published in <em>Development</em>) discovered that BICC1 <strong>binds to and stabilizes <em>Pkd2</em> mRNA</strong>, enhancing Polycystin-2 expression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17">pmc.ncbi.nlm.nih.gov</a>). In Bicc1-deficient mouse kidneys, Pkd2 levels are greatly reduced, whereas restoring Pkd2 expression can rescue some defects (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17">pmc.ncbi.nlm.nih.gov</a>). BICC1 regulates Pkd2 via a microRNA-dependent mechanism: the <em>Pkd2</em> 3‚Ä≤UTR contains a binding site for the microRNA <strong>miR-17</strong>, which normally represses Pkd2. BICC1 was shown to <strong>antagonize miR-17</strong> activity on this 3‚Ä≤UTR (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=match%20at%20L598%20However%2C%20the,actually%20releases%20the%20repression%20by">pmc.ncbi.nlm.nih.gov</a>). In cells, BICC1 binding counteracts miR-17‚Äìmediated translational inhibition, resulting in higher Pkd2 protein output (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=match%20at%20L598%20However%2C%20the,actually%20releases%20the%20repression%20by">pmc.ncbi.nlm.nih.gov</a>). Consistently, in <em>Xenopus</em> embryos Bicc1 knockdown caused pronephric (embryonic kidney) cysts that could be <strong>rescued by inhibiting miR-17</strong>, indicating Bicc1 and miR-17 converge on Pkd2 regulation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to">pmc.ncbi.nlm.nih.gov</a>). This <strong>‚Äúrelief of repression‚Äù</strong> model is somewhat unique, as BICC1 in this context acts to <strong>promote</strong> a target‚Äôs expression by blocking a microRNA. It highlights that BICC1 can either repress or de-repress targets depending on the interplay with other regulators.</p>
<p>Beyond Pkd2, BICC1 broadly modulates the cAMP signaling pathway in kidney epithelia ‚Äì a pathway central to cystogenesis. Cystic growth is fueled by elevated cyclic AMP (cAMP) levels driving proliferation and fluid secretion in tubule cells. Normally, BICC1 helps keep cAMP in check by <strong>repressing mRNAs that would otherwise raise cAMP production</strong>. Notably, BICC1 binds and downregulates the mRNA encoding <strong>adenylate cyclase 6 (ADCY6)</strong>, a major cAMP-producing enzyme (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA">www.frontiersin.org</a>). In Bicc1-null mouse kidneys, ADCY6 protein is upregulated due to loss of BICC1-mediated silencing, leading to excess cAMP signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>). BICC1 was also found to bind mRNA for <strong>PKA inhibitor-Œ± (PKIŒ±)</strong>, a feedback regulator of Protein Kinase A (PKA) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA">www.frontiersin.org</a>). Paradoxically, silencing <em>PKIŒ±</em> would tend to increase PKA activity, but in context this may fine-tune cAMP pathway dynamics. The net effect of BICC1 loss is a pathogenic increase in cAMP/PKA activity in kidney cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA">www.frontiersin.org</a>). This excess cAMP promotes cyst formation ‚Äì a hallmark of polycystic kidney disease. In support of this, <em>Bicc1</em> mutant mice show aberrant PKA-driven cell proliferation in renal tubules and misregulated epithelial cell adhesion (disrupted E-cadherin at cell junctions) (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=131,89%2C%20428%E2%80%93436%20%282010">www.nature.com</a>), consistent with a cAMP/PKA-mediated cystic phenotype. Combining these findings, researchers in 2012 proposed that BICC1 normally functions <strong>downstream of Dicer</strong> (miRNA processor) to bring together target mRNAs and the Ago2 microRNA-silencing complex (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=enzyme%20Dicer%20to%20mediate%20an,cognate%20microRNAs%20and%20the%20Bicc1">www.frontiersin.org</a>). In the kidney, this means BICC1 cooperates with microRNAs to ensure proper post-transcriptional silencing of cAMP-promoting genes; without BICC1, that silencing is lifted, explaining cystic kidney pathology as a consequence of microRNA pathway dysregulation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Summary of BICC1 in kidney:</strong> BICC1 maintains renal tubule integrity by (1) upregulating <strong>Polycystin-2</strong> (a cyst-preventing factor) via miR-17 antagonism, and (2) downregulating <strong>cAMP stimulatory proteins</strong> (like AC6) via microRNA-mediated silencing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>). These actions place BICC1 as a pivotal node connecting <strong>ciliary signaling (polycystins)</strong>, <strong>microRNA pathways</strong>, and <strong>epithelial cyclic AMP homeostasis</strong>. Its importance is underscored by the polycystic disease that results from BICC1 dysfunction in both animals and humans (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,17">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed">pmc.ncbi.nlm.nih.gov</a>).</p>
<h1 id="recent-developments-20232024">Recent Developments (2023‚Äì2024)</h1>
<p>Research in the past two years has uncovered new roles for BICC1, especially in disease contexts like cancer, and has provided deeper molecular insights. Below are key recent findings and expert analyses:</p>
<p><strong>BICC1 in Cancer and Disease:</strong> Although historically studied in developmental biology, BICC1 has emerged as a significant player in cancer biology in recent studies (2021‚Äì2023). For example, <strong>BICC1 has been implicated in pancreatic cancer aggressiveness</strong>. Huang <em>et al.</em> (2023, <em>Signal Transduct. Target. Ther.</em>) identified BICC1 as one of the top upregulated genes in pancreatic ductal adenocarcinoma associated with angiogenesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=analysis%20showed%20that%20BICC1%20was,In%20cells%20and%20mice">pmc.ncbi.nlm.nih.gov</a>). Their analysis of patient datasets showed <strong>BICC1 mRNA is overexpressed in pancreatic tumors</strong>, with a mean expression of ~25 TPM in tumors versus much lower levels in normal tissue or other cancers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=significance%20of%20BICC1%20in%20PAAD,levels%20had%20a%20significantly%20longer">pmc.ncbi.nlm.nih.gov</a>). High BICC1 expression correlated with <strong>larger tumor size, increased microvessel density, and shorter patient survival</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=analysis%20showed%20that%20BICC1%20was,In%20cells%20and%20mice">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in">pmc.ncbi.nlm.nih.gov</a>). Notably, pancreatic cancer patients whose tumors had <strong>high BICC1 levels had significantly worse overall survival</strong> than those with low BICC1 (log-rank <em>p</em> = 0.0077) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L186%20overall%20survival,0.001%2C%20Fig.%201d%20and">pmc.ncbi.nlm.nih.gov</a>). This identifies BICC1 as a potential <strong>prognostic biomarker</strong> in pancreatic cancer.</p>
<p>Mechanistically, Huang <em>et al.</em> uncovered a novel pathway by which BICC1 drives <strong>VEGF-independent angiogenesis</strong> in pancreatic tumors. They found that <strong>BICC1 binds to the 3‚Ä≤UTR of <em>Lipocalin-2 (LCN2)</em> mRNA</strong> and post-transcriptionally <strong>upregulates LCN2</strong> expression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=BICC1%20binds%20to%20the%203%E2%80%99UTR,factor%20CXCL1%2C%20leading%20to%20VEGF">pmc.ncbi.nlm.nih.gov</a>). LCN2 (also known as NGAL) is a secreted protein that, when elevated, binds its receptor (24p3R) and triggers the JAK2/STAT3 signaling cascade. In BICC1-overexpressing pancreatic cancer cells and xenografts, high LCN2 led to activation of JAK2/STAT3 and consequent overproduction of <strong>CXCL1</strong>, a pro-angiogenic chemokine (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds">pmc.ncbi.nlm.nih.gov</a>). This sequence ‚Äì <strong>BICC1 ‚Üí LCN2 ‚Üí STAT3 ‚Üí CXCL1</strong> ‚Äì promoted robust blood vessel formation in tumors <strong>independent of VEGF</strong> signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>). As a result, tumors with high BICC1 were less responsive to VEGF-targeted therapies (like bevacizumab), since they could sustain angiogenesis through the alternative LCN2/CXCL1 pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=effect%20of%20gemcitabine,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>). Encouragingly, blocking the BICC1‚ÄìLCN2 axis, either by BICC1 knockdown or LCN2 neutralization, <strong>reduced microvessel density and tumor growth</strong> in mouse models (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=BICC1%20binds%20to%20the%203%E2%80%99UTR,factor%20CXCL1%2C%20leading%20to%20VEGF">pmc.ncbi.nlm.nih.gov</a>). It also enhanced the efficacy of chemotherapy (gemcitabine) in these tumors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>). This finding reveals a <strong>new function for BICC1 in cancer:</strong> acting as an RNA-binding oncogene that promotes angiogenesis and therapy resistance. It also suggests that targeting BICC1 or its controlled network (for example, STAT3 or LCN2) might improve outcomes in BICC1-high cancers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>). The authors propose BICC1/LCN2 signaling as a promising <strong>therapeutic target</strong> for pancreatic cancer, especially to overcome resistance to anti-VEGF treatment (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=effect%20of%20gemcitabine,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>).</p>
<p>Another <strong>2023 study (Meng <em>et al.</em>, BMC Med Genomics, Oct 2023)</strong> reinforces BICC1‚Äôs role in pancreatic cancer, focusing on metastasis and the tumor microenvironment. This study identified BICC1 as a gene significantly associated with <strong>lymph node metastasis</strong> in pancreatic cancer, and found that <strong>high BICC1 expression correlates with an epithelial-to-mesenchymal transition (EMT) gene signature and immunosuppressive microenvironment</strong> markers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in">pmc.ncbi.nlm.nih.gov</a>). In silico analyses showed BICC1 levels positively correlate with <strong>stromal content and immune cell infiltration</strong> scores (Pearson <em>r</em> ‚âà 0.54 for stromal, 0.45 for immune, <em>p</em> &lt; 0.001) in tumors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=expression%20and%20stromal%20score%20%28r%E2%80%89%3D%E2%80%890,cells%2C%20M0%20macrophage%2C%20M1%20macrophage">pmc.ncbi.nlm.nih.gov</a>). Specifically, tumors with elevated BICC1 had increased infiltration of CD8‚Å∫ T cells, activated memory CD4‚Å∫ T cells, and M1 macrophages, but also higher expression of immune checkpoints like PD-1 (PDCD1) and CTLA-4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Correlation%20between%20BICC1%20expression%20and,immune%20characteristics%20in%20PC">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Correlation%20of%20BICC1%20expression%20with,4">pmc.ncbi.nlm.nih.gov</a>). Clinically, the study found <strong>BICC1 to be an independent prognostic factor</strong>: in a multivariate Cox analysis, high BICC1 was associated with poorer survival (hazard ratio significant with <em>p</em> ~0.03) after adjusting for tumor stage (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=including%20age%2C%20gender%2C%20T%20stage%2C,009%29%2C%20and%20N">pmc.ncbi.nlm.nih.gov</a>). The authors suggest BICC1 might promote pancreatic tumor progression by inducing EMT (thus enhancing invasion) and modulating the tumor microenvironment to favor immune evasion (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=furthermore%20confirm%20that%20BICC1%20influences,pathway%20to%20promote%20PC%20progression">pmc.ncbi.nlm.nih.gov</a>). They even explored drug sensitivity data, noting that <strong>BICC1-high samples might respond differently to certain immune checkpoint inhibitors</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=match%20at%20L530%20mobilizing%20immune,future%20research%20in%20PC%20immunotherapy">pmc.ncbi.nlm.nih.gov</a>). These findings, while correlative, position BICC1 as a potential <strong>biomarker for aggressive, immune-interactive tumors</strong>, and raise the prospect that BICC1 could be targeted to alter tumor‚Äìstroma interactions.</p>
<p><strong>Other cancers:</strong> Emerging evidence links BICC1 dysregulation to additional malignancies. A 2020 study noted <strong>BICC1 overexpression in oral squamous cell carcinoma</strong>, where it was associated with increased cell viability and reduced apoptosis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=Studies%20showed%20that%20BICC1%20is,revealed%20that%20BICC1%20promotes%20the">pmc.ncbi.nlm.nih.gov</a>). BICC1 has also been reported as a putative prognostic biomarker in <strong>gastric cancer</strong> (correlating with immune cell infiltration and worse outcomes) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=match%20at%20L652%20BICC1%20as,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>), and aberrant BICC1 expression has been observed in Wilms‚Äô tumor (pediatric kidney cancer) and non-small cell lung cancer in some datasets (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found">pmc.ncbi.nlm.nih.gov</a>). These studies are largely high-throughput or bioinformatic analyses, so the precise mechanisms are not yet fully validated. However, the consistent theme is that <strong>BICC1 upregulation tends to correlate with tumor progression</strong>, possibly by enabling pro-survival pathways or altering cytokine networks. It will be important for future research to experimentally test BICC1‚Äôs role in these cancers and whether it could be exploited for therapy or diagnosis.</p>
<p><strong>Cholangiocarcinoma fusion gene:</strong> One of the most striking ‚Äúreal-world‚Äù findings involving BICC1 is its role in a gene fusion that drives a subset of <strong>intrahepatic cholangiocarcinoma</strong> (bile duct cancer). Genomic studies of cholangiocarcinoma (2014‚Äì2021) revealed that <em>BICC1</em> is a recurrent fusion partner of the <strong>FGFR2</strong> gene in these tumors (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). In such tumors, a chromosomal translocation fuses the N-terminal part of BICC1 (including the SAM domain) to the FGFR2 tyrosine kinase domain (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). The resulting <strong>FGFR2‚ÄìBICC1 fusion protein</strong> contains the FGFR2 kinase, which dimerizes abnormally via the BICC1 SAM polymerization motif (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). This leads to constitutive autophosphorylation of FGFR2 and uncontrolled mitogenic signaling, effectively an oncogenic driver of the cancer (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). The FGFR2-BICC1 fusion defines a unique molecular subtype of cholangiocarcinoma that is clinically actionable: patients with FGFR2‚ÄìBICC1 (or similar FGFR2 fusions) respond to FGFR inhibitors (such as pemigatinib or sorafenib) with tumor shrinkage (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=cholangiocarcinoma%20who%20had%20FGFR2,is%20sensitive%20to%20sorafenib%20therapy">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=no%20response%20and%20disease%20progression%2C,there%20were%20no%20adverse%20events">pmc.ncbi.nlm.nih.gov</a>). In one case report, a patient with chemo-refractory cholangiocarcinoma harboring <em>FGFR2-BICC1</em> showed a partial response to the multi-kinase inhibitor sorafenib, highlighting the therapeutic relevance of this fusion (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=sequencing%20,is%20sensitive%20to%20sorafenib%20therapy">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=no%20response%20and%20disease%20progression%2C,there%20were%20no%20adverse%20events">pmc.ncbi.nlm.nih.gov</a>). Importantly, BICC1‚Äôs contribution to the fusion is not benign ‚Äì its <strong>oligomerization domain</strong> likely confers the ligand-independent clustering that activates FGFR2. Researchers have pointed out that disrupting the BICC1 SAM polymer interface could be a strategy to interfere with these oncogenic fusions (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=match%20at%20L579%20kinase%20that,new%20treatments%20for%20these%20cancers">www.frontiersin.org</a>). Thus, BICC1 has entered the realm of precision oncology as part of a <strong>chimeric oncoprotein</strong>, and testing for <em>FGFR2-BICC1</em> fusions is now a routine part of molecular diagnostics in cholangiocarcinoma (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>).</p>
<h2 id="expert-opinions-and-current-understanding">Expert Opinions and Current Understanding</h2>
<p><em>‚ÄúBicaudal-C (BICC1) is an evolutionarily conserved RNA binding protein that functions in a regulatory capacity in a variety of contexts,‚Äù</em> wrote Megan Dowdle and colleagues in a 2022 Frontiers review (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental">www.frontiersin.org</a>). Experts emphasize that <strong>BICC1‚Äôs fundamental role is to organize post-transcriptional regulatory complexes</strong> that control where, when, and how much certain proteins are made. Peter Lasko, who co-discovered <em>Bic-C</em> in flies, described the Bic-C family as <em>‚Äúdevelopmental translational regulators‚Äù</em> that tune the local translation of mRNAs during early body plan formation (<a href="https://pubmed.ncbi.nlm.nih.gov/31838063/#:~:text=satellites%20that%20perturb%20complex%20protein,networks">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5678326/#:~:text=Assessment%20of%20BicC%20family%20RNA,PMC%20Image%3A%20Close">pmc.ncbi.nlm.nih.gov</a>). This perspective is supported by numerous studies across species showing BICC1 prevents inappropriate expression of cell fate determinants (like Oskar, Cripto, Wnt11) outside their proper domain.</p>
<p>Renowned nephrology researchers (e.g. G. Walz and colleagues) have highlighted BICC1‚Äôs importance in kidney disease. In a 2021 <em>Nature Reviews Nephrology</em> article on RNA-binding proteins in the kidney, BICC1 is noted as a gene <em>‚Äúassociated with PKD in vertebrates,‚Äù</em> with mutations causing cystic phenotypes from fruit flies‚Äô Malpighian tubules to human kidneys (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=example%2C%20mutations%20in%20BICC1%20lead,associated%20with%20PKD%20in%20vertebrates">www.nature.com</a>). The review discusses how BICC1 orchestrates a microRNA-based regulatory mechanism to maintain tubule differentiation ‚Äì <em>‚Äúthe kidney phenotype in Bicc1^-/-^ mice is caused by dysregulation of a microRNA-based translational control mechanism‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism">pmc.ncbi.nlm.nih.gov</a>). Researchers like Oliver Wessely have proposed a model wherein <strong>BICC1 serves as a scaffold</strong>, bringing together the 3‚Ä≤UTRs of target mRNAs and the microRNA/Ago2 complexes that regulate them (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1">www.frontiersin.org</a>). In this model, <strong>BICC1 doesn‚Äôt simply block or enable translation, but rather helps present mRNAs to the silencing machinery in a controlled manner</strong> (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=enzyme%20Dicer%20to%20mediate%20an,cognate%20microRNAs%20and%20the%20Bicc1">www.frontiersin.org</a>). Defects in BICC1 upset this balance ‚Äì either freeing transcripts that should be silenced (as with Pkd2 in cystic kidneys) or failing to repress transcripts that drive pathology (as with Adcy6 in cystic kidneys, or LCN2 in cancer).</p>
<p>Structural biologists have provided insight into <strong>BICC1‚Äôs SAM-domain polymerization</strong>, underscoring its novel mechanism of action. A 2018 study solved the crystal structure of the BICC1 SAM polymer, revealing a head-to-tail helical assembly (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018">www.nature.com</a>). The authors (Roth√© <em>et al.</em>, <em>Structure</em> 2018) mapped how disease-associated mutations in BICC1 or its partners ANKS3/ANKS6 disrupt this polymer interface (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018">www.nature.com</a>). Their conclusion: <em>‚Äúpolymerization is a novel disease-relevant mechanism both to stabilize Bicc1 and to present associated mRNAs in specific silencing platforms‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>). In other words, BICC1‚Äôs self-assembly is not just a quirk of cell biology, but a crucial aspect of how it segregates and silences mRNAs, with failure of this assembly leading to disease.</p>
<p>Cancer biologists are increasingly considering BICC1 in the context of tumor progression. As noted by Huang <em>et al.</em> (2023), <em>‚Äúin recent years, Bicaudal-C1 (BICC1) has been found to play essential roles in human physiology and pathology‚Äù</em>, including in cancers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L108%20recent%20years%2C,in%20oral%20cancer%2C%20promotes%20tumor">pmc.ncbi.nlm.nih.gov</a>). They point out that <strong>BICC1 was known in developmental biology for decades, but only now is evidence mounting for its role in tumor angiogenesis, EMT, and chemoresistance</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=recent%20years%2C%20Bicaudal,in%20oral%20cancer%2C%20promotes%20tumor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found">pmc.ncbi.nlm.nih.gov</a>). Some experts propose that BICC1 could be an <em>‚ÄúRNA-binding oncogene‚Äù</em> in certain contexts ‚Äì a relatively new concept, since most well-known cancer drivers are DNA-binding transcription factors or signaling proteins. The idea is that by persistently upregulating pro-tumoral factors (like LCN2 or others) through mRNA stabilization, BICC1 can confer an advantage to cancer cells. However, this field is nascent, and researchers caution that <em>association does not prove causation</em> in the cancer data. Functional experiments (knockdowns, etc.) like those by Huang et al. support a causative role of BICC1 in promoting angiogenesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>), but further studies are needed to generalize these findings to other cancers.</p>
<h2 id="current-and-future-applications">Current and Future Applications</h2>
<p><strong>Functional Annotation and Disease Modeling:</strong> The detailed understanding of BICC1‚Äôs function is being applied in both basic and translational research. For instance, the identification of BICC1 target mRNA motifs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward">pmc.ncbi.nlm.nih.gov</a>) provides a tool for predicting <strong>new BICC1 targets</strong> via bioinformatics, which can reveal what pathways BICC1 might regulate. Likewise, the creation of <em>Bicc1</em> knockout and mutant mice has established valuable <strong>disease models</strong> for PKD and biliary developmental defects (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>). These models are used to test therapeutic interventions; for example, since Bicc1 loss causes cAMP upregulation, researchers have tried cAMP-lowering treatments (like vasopressin V2 receptor antagonists) in <em>Bicc1</em> mutant mice to see if cystic disease can be ameliorated. Such studies are ongoing, leveraging knowledge of BICC1‚Äôs pathway interactions.</p>
<p><strong>Molecular Diagnostics:</strong> The discovery of FGFR2‚ÄìBICC1 fusions in cholangiocarcinoma has immediate clinical utility. Diagnostic labs now routinely screen cholangiocarcinoma patients for FGFR2 gene fusions (using NGS panels or FISH), and <em>BICC1</em> is one of the frequent fusion partners (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). Identifying a <em>BICC1</em> fusion can qualify a patient for targeted therapy (FGFR2 inhibitors are FDA-approved for FGFR2-fusion cholangiocarcinoma). This is a direct real-world implementation of BICC1 research: the gene‚Äôs involvement in a fusion oncogene guides <strong>personalized treatment</strong> decisions.</p>
<p><strong>Therapeutic Target Potential:</strong> While no drugs currently target BICC1 directly, its role in disease pathways presents some opportunities. In polycystic kidney disease, enhancing BICC1 activity or mimicking its function could be beneficial ‚Äì for example, a small molecule stabilizer of BICC1‚Äôs SAM polymer (if developed) might boost BICC1‚Äôs repression of cyst-promoting mRNAs. Conversely, in BICC1-driven cancers, <strong>inhibiting BICC1</strong> might suppress tumor growth. Designing inhibitors for an RNA-binding protein is challenging, but one idea is disrupting the critical KH domain‚ÄìRNA interaction or the SAM‚ÄìSAM multimerization. The structural data on BICC1 SAM oligomers (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018">www.nature.com</a>) could inform <em>SAM domain inhibitors</em> that prevent BICC1 polymerization (somewhat akin to polymerization inhibitors used for other oligomeric proteins). Additionally, targeting the downstream effects of BICC1 is a practical approach: for instance, Huang et al. suggest blocking the BICC1‚ÄìLCN2‚ÄìSTAT3 pathway (perhaps with JAK/STAT3 inhibitors or LCN2 antibodies) to combat BICC1-driven angiogenesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients">pmc.ncbi.nlm.nih.gov</a>). In summary, <strong>BICC1 sits at a key junction of developmental and disease pathways</strong>, and ongoing research aims to translate this knowledge into targeted interventions ‚Äì whether by using BICC1 as a disease marker, or by pharmacologically modulating its pathway for therapeutic benefit.</p>
<p><strong>Statistics and Data from Recent Studies:</strong> Recent studies provide quantitative data underlining BICC1‚Äôs significance:</p>
<ul>
<li>
<p><em>Development:</em> Bicc1 mutant mice have &gt;5‚Äì10√ó elevated kidney cyst volumes compared to wild-type, and 100% penetrance of cystic disease by early adulthood (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its">pmc.ncbi.nlm.nih.gov</a>). In <em>Xenopus</em>, over 60 direct mRNA targets of Bicc1 were identified, demonstrating the breadth of its regulatory network (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,41%20Maerker%20et%20al">www.frontiersin.org</a>).</p>
</li>
<li>
<p><em>Human disease:</em> In a 2012 report, two unrelated patients with biallelic <em>BICC1</em> mutations presented with cystic kidneys and elevated Wnt target gene expression; fibroblasts from these patients showed ~2-fold higher Œ≤-catenin activity than controls (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed">pmc.ncbi.nlm.nih.gov</a>). This links BICC1 loss to quantifiable Wnt pathway dysregulation in human tissue.</p>
</li>
<li>
<p><em>Cancer analytics:</em> As mentioned, in TCGA data for pancreatic cancer, BICC1-high tumors had significantly shorter median survival (~14 months) versus BICC1-low tumors (~18+ months) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L186%20overall%20survival,0.001%2C%20Fig.%201d%20and">pmc.ncbi.nlm.nih.gov</a>). Huang et al. also reported that silencing BICC1 in pancreatic cancer cell lines <strong>reduced CXCL1 secretion by ~50%</strong> and microvessel density in xenografts by 40‚Äì50% (quantified by CD31 staining) relative to controls (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L134%20independent%20angiogenesis,for%20the%20treatment%20of%20PAAD">pmc.ncbi.nlm.nih.gov</a>). Meng et al. (2023) showed that BICC1 expression had a strong positive correlation with stromal score (Pearson <em>r</em> = 0.606) and immune score (<em>r</em> = 0.445) in tumors, with <em>p</em> &lt; 0.001 for both (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=expression%20and%20stromal%20score%20%28r%E2%80%89%3D%E2%80%890,cells%2C%20M0%20macrophage%2C%20M1%20macrophage">pmc.ncbi.nlm.nih.gov</a>). Their Cox regression analysis gave a hazard ratio ~1.7 for high BICC1 (95% CI ~1.06‚Äì2.8) in pancreatic cancer survival (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=including%20age%2C%20gender%2C%20T%20stage%2C,009%29%2C%20and%20N">pmc.ncbi.nlm.nih.gov</a>).</p>
</li>
<li>
<p><em>Cholangiocarcinoma:</em> FGFR2‚ÄìBICC1 fusions occur in an estimated <strong>5‚Äì15%</strong> of intrahepatic cholangiocarcinomas (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). Patients with these fusions on FGFR inhibitor therapy have reported response rates around 30‚Äì40% in clinical trials (these data are aggregated for all FGFR2 fusions, not only BICC1) ‚Äì illustrating a tangible benefit from identifying the BICC1 fusion subtype.</p>
</li>
</ul>
<hr />
<p><strong>Conclusion:</strong> BICC1 serves as a multifaceted regulator of gene expression, linking mRNA-level control to large-scale outcomes in development and disease. Current understanding, supported by recent research, defines BICC1 as an <strong>mRNA-binding scaffolding protein</strong> that assembles translational silencing complexes at specific 3‚Ä≤UTRs, thereby shaping protein expression patterns crucial for organ development (kidney, laterality, etc.) and for preventing pathological states like cyst formation. Cutting-edge studies from 2023 have expanded BICC1‚Äôs relevance to oncology, identifying it as a player in tumor angiogenesis, EMT, and the tumor immune microenvironment. With its deep evolutionary conservation and involvement in fundamental pathways (Wnt, TGF-Œ≤/Nodal, cAMP/PKA), BICC1 is increasingly recognized as a key post-transcriptional ‚Äúhub.‚Äù <strong>Authoritative reviews and experts</strong> describe BICC1 as <em>‚Äúa post-transcriptional regulator of cell fates and functions‚Äù</em> (<a href="https://pubmed.ncbi.nlm.nih.gov/31838063/#:~:text=satellites%20that%20perturb%20complex%20protein,networks">pubmed.ncbi.nlm.nih.gov</a>) and a paradigm of how RNA-binding proteins can dictate developmental processes and disease outcomes. Ongoing research is likely to continue unveiling BICC1‚Äôs target networks and interacting partners (such as ANKS6/SamCystin in ciliary signaling (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=kidney%20disease,383%2C%2016%E2%80%9321%20%282009">www.nature.com</a>)), and may open up new avenues for therapeutic intervention by modulating this RNA-centric regulatory mechanism. In summary, <strong>BICC1 (Q9H694)</strong> is a crucial human protein that translates the information encoded in mRNA 3‚Ä≤UTRs into spatiotemporal control of protein synthesis, with broad implications from embryogenesis to adult disease.</p>
<p><strong>References:</strong> <em>(Key sources with publication date and URL)</em></p>
<ul>
<li>Tran et al., <em>Development</em>, April 2010 ‚Äì <em>‚ÄúThe RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to">pmc.ncbi.nlm.nih.gov</a>) (demonstrated BICC1‚Äôs role in Pkd2/miR-17 and cystic kidneys).  </li>
<li>Kraus et al., <em>Human Mutation</em>, 2012 ‚Äì <em>‚ÄúTwo mutations in human BICC1‚Ä¶ associated with cystic renal dysplasia‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed">pmc.ncbi.nlm.nih.gov</a>) (linked human BICC1 mutations to Wnt hyperactivity and kidney dysplasia).  </li>
<li>Zhang et al., <em>J. Biol. Chem.</em>, Mar 2014 ‚Äì <em>‚ÄúDeterminants of RNA binding and translational repression by Bicaudal-C‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=This%2032,control%20cellular%20function%20in%20metazoans">pmc.ncbi.nlm.nih.gov</a>) (identified a 32-nt RNA binding element for BICC1).  </li>
<li>Roth√© et al., <em>Mol. Cell. Biol.</em>, Oct 2015 ‚Äì <em>‚ÄúBicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms">pmc.ncbi.nlm.nih.gov</a>) (elucidated the SAM-domain polymerization mechanism for mRNA silencing; linked BICC1 to Dvl2/Wnt and cyst phenotypes).  </li>
<li>Dowdle et al., <em>Front. Cell Dev. Biol.</em>, Sept 2022 ‚Äì <em>‚ÄúBicaudal-C: Post-transcriptional regulator of cell fates and functions‚Äù</em> (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a">www.frontiersin.org</a>) (comprehensive review of BICC1 in development; discusses target networks and mechanisms).  </li>
<li>Huang et al., <em>Signal Transduct. Target. Ther.</em>, July 2023 ‚Äì <em>‚ÄúBICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in">pmc.ncbi.nlm.nih.gov</a>) (new finding of BICC1‚ÄìLCN2‚ÄìCXCL1 axis in pancreatic cancer; clinical correlations).  </li>
<li>Meng et al., <em>BMC Med Genomics</em>, Oct 2023 ‚Äì <em>‚ÄúBICC1 promotes tumor progression by EMT and immune infiltration in pancreatic cancer‚Äù</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in">pmc.ncbi.nlm.nih.gov</a>) (bioinformatics study linking BICC1 to metastasis, EMT, and immune features in pancreatic cancer).  </li>
<li>Nature Reviews Nephrology, May 2021 ‚Äì <em>‚ÄúRNA-binding proteins and their role in kidney disease‚Äù</em> (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=example%2C%20mutations%20in%20BICC1%20lead,associated%20with%20PKD%20in%20vertebrates">www.nature.com</a>) (<a href="https://www.nature.com/articles/s41581-021-00497-1#:~:text=133,33%2C%2086%E2%80%9390%20%282012">www.nature.com</a>) (high-level reference to BICC1 in context of renal pathophysiology).  </li>
<li>Arai et al., <em>Hepatology</em>, 2014 &amp; Scheiter et al., <em>Cytokine Growth Factor Rev.</em>, 2021 ‚Äì (characterization of FGFR2‚ÄìBICC1 fusions in cholangiocarcinoma) (<a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these">www.frontiersin.org</a>). These and other studies collectively form the basis of our current understanding of BICC1‚Äôs function and significance.</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=428, start_index=235, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental')</li>
<li>AnnotationURLCitation(end_index=766, start_index=573, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental')</li>
<li>AnnotationURLCitation(end_index=1117, start_index=927, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,protein')</li>
<li>AnnotationURLCitation(end_index=1521, start_index=1293, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,Sequence%20conservation%20among%20vertebrates')</li>
<li>AnnotationURLCitation(end_index=1918, start_index=1718, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,metabolism%20functions%20in%20vertebrate%20embryos')</li>
<li>AnnotationURLCitation(end_index=2071, start_index=1919, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=2504, start_index=2352, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=2661, start_index=2505, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288')</li>
<li>AnnotationURLCitation(end_index=3038, start_index=2901, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward')</li>
<li>AnnotationURLCitation(end_index=3356, start_index=3219, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward')</li>
<li>AnnotationURLCitation(end_index=3715, start_index=3605, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=sequence%20%28see%20Fig,16')</li>
<li>AnnotationURLCitation(end_index=3803, start_index=3716, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=,16')</li>
<li>AnnotationURLCitation(end_index=4303, start_index=4172, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism')</li>
<li>AnnotationURLCitation(end_index=4599, start_index=4468, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism')</li>
<li>AnnotationURLCitation(end_index=4883, start_index=4755, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Bicc1%20is%20localized%20in%20cytoplasmic,42')</li>
<li>AnnotationURLCitation(end_index=5129, start_index=5001, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Bicc1%20is%20localized%20in%20cytoplasmic,42')</li>
<li>AnnotationURLCitation(end_index=5422, start_index=5283, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=including%20adenylate%20cyclase%206%20%28AC6%29,catenin')</li>
<li>AnnotationURLCitation(end_index=5588, start_index=5423, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=then%20mutated%20the%20SAM%20domain,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=5883, start_index=5715, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=polymerizes%20in%20vitro%20and%20localizes,conclude%20that%20polymerization%20is%20a')</li>
<li>AnnotationURLCitation(end_index=6048, start_index=5884, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=polymerize%20Bicc1%20in%20a%20left,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=6448, start_index=6283, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=then%20mutated%20the%20SAM%20domain,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=6771, start_index=6598, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,stabilize%20Bicc1%20and%20to%20present')</li>
<li>AnnotationURLCitation(end_index=7184, start_index=7047, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward')</li>
<li>AnnotationURLCitation(end_index=7377, start_index=7185, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=mRNA%20features%20required%20for%20Bicaudal,binding')</li>
<li>AnnotationURLCitation(end_index=7721, start_index=7522, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,41%20Maerker%20et%20al')</li>
<li>AnnotationURLCitation(end_index=8086, start_index=7874, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a')</li>
<li>AnnotationURLCitation(end_index=8286, start_index=8087, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=targets,development%20and%20potentially%20other%20contexts')</li>
<li>AnnotationURLCitation(end_index=8654, start_index=8442, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a')</li>
<li>AnnotationURLCitation(end_index=8795, start_index=8655, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=This%2032,control%20cellular%20function%20in%20metazoans')</li>
<li>AnnotationURLCitation(end_index=9205, start_index=9068, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward')</li>
<li>AnnotationURLCitation(end_index=9377, start_index=9206, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Here%2C%20we%20used%20EMSA%2C%20RNase,mediated%20translational%20repression%20in%20vivo')</li>
<li>AnnotationURLCitation(end_index=10021, start_index=9906, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=RNA,C%20has%20been%20shown%20to')</li>
<li>AnnotationURLCitation(end_index=10402, start_index=10250, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=10559, start_index=10403, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288')</li>
<li>AnnotationURLCitation(end_index=10940, start_index=10788, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=11097, start_index=10941, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288')</li>
<li>AnnotationURLCitation(end_index=11551, start_index=11408, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=match%20at%20L106%20%2831%E2%80%9334%29,Together%2C%20these')</li>
<li>AnnotationURLCitation(end_index=11859, start_index=11716, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=match%20at%20L106%20%2831%E2%80%9334%29,Together%2C%20these')</li>
<li>AnnotationURLCitation(end_index=12213, start_index=12050, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=%28Mesner%20et%20al,42')</li>
<li>AnnotationURLCitation(end_index=12612, start_index=12491, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=13179, start_index=12999, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=13597, start_index=13363, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=these%20targets%20were%20validated%20using,development%20and%20potentially%20other%20contexts')</li>
<li>AnnotationURLCitation(end_index=14044, start_index=13892, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=14257, start_index=14045, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a')</li>
<li>AnnotationURLCitation(end_index=14576, start_index=14391, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,that%20Bicc1%20proteins%20have%20on')</li>
<li>AnnotationURLCitation(end_index=14998, start_index=14808, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,protein')</li>
<li>AnnotationURLCitation(end_index=15181, start_index=14999, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=KH%20domains%20contain%20GXXG%20motifs,27')</li>
<li>AnnotationURLCitation(end_index=15731, start_index=15503, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Comparison%20of%20Bicc1%20proteins%20from,Sequence%20conservation%20among%20vertebrates')</li>
<li>AnnotationURLCitation(end_index=16004, start_index=15848, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=Recently%2C%20we%20identified%20the%20Xenopus,C%20binding%20sites%20%288')</li>
<li>AnnotationURLCitation(end_index=16264, start_index=16100, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=health%20of%20several%20adult%20tissues,organism%20have%20not%20been%20described')</li>
<li>AnnotationURLCitation(end_index=16476, start_index=16265, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=their%203%E2%80%B2UTRs%20was%20inhibited%20by,42%20Minegishi%20et%20al')</li>
<li>AnnotationURLCitation(end_index=17079, start_index=16868, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Multiple%20lines%20of%20evidence%20have,of%20mouse%20Bicc1%20as%20well')</li>
<li>AnnotationURLCitation(end_index=17393, start_index=17271, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its')</li>
<li>AnnotationURLCitation(end_index=17521, start_index=17394, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=mutants%20are%20characterized%20by%20the,17')</li>
<li>AnnotationURLCitation(end_index=17787, start_index=17665, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its')</li>
<li>AnnotationURLCitation(end_index=17915, start_index=17788, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=mutants%20are%20characterized%20by%20the,17')</li>
<li>AnnotationURLCitation(end_index=18350, start_index=18259, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed')</li>
<li>AnnotationURLCitation(end_index=18809, start_index=18585, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=organisms%20mutations%20of%20mouse%20Bicc1,embryos%20result%20in%20cystic%20kidneys')</li>
<li>AnnotationURLCitation(end_index=19350, start_index=19226, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17')</li>
<li>AnnotationURLCitation(end_index=19601, start_index=19477, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17')</li>
<li>AnnotationURLCitation(end_index=19971, start_index=19825, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to')</li>
<li>AnnotationURLCitation(end_index=20136, start_index=19972, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=match%20at%20L598%20However%2C%20the,actually%20releases%20the%20repression%20by')</li>
<li>AnnotationURLCitation(end_index=20420, start_index=20256, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=match%20at%20L598%20However%2C%20the,actually%20releases%20the%20repression%20by')</li>
<li>AnnotationURLCitation(end_index=20766, start_index=20620, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to')</li>
<li>AnnotationURLCitation(end_index=21625, start_index=21504, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=21846, start_index=21626, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA')</li>
<li>AnnotationURLCitation(end_index=22101, start_index=21980, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=22436, start_index=22216, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA')</li>
<li>AnnotationURLCitation(end_index=22776, start_index=22655, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=22997, start_index=22777, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=The%20analysis%20of%20proteins%20whose,Additionally%2C%20comparison%20of%20mRNA')</li>
<li>AnnotationURLCitation(end_index=23383, start_index=23267, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=131,89%2C%20428%E2%80%93436%20%282010')</li>
<li>AnnotationURLCitation(end_index=23850, start_index=23637, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1')</li>
<li>AnnotationURLCitation(end_index=24066, start_index=23851, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=enzyme%20Dicer%20to%20mediate%20an,cognate%20microRNAs%20and%20the%20Bicc1')</li>
<li>AnnotationURLCitation(end_index=24457, start_index=24326, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism')</li>
<li>AnnotationURLCitation(end_index=24838, start_index=24714, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=reminiscent%20of%20human%20forms%20of,17')</li>
<li>AnnotationURLCitation(end_index=24960, start_index=24839, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=25335, start_index=25239, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,17')</li>
<li>AnnotationURLCitation(end_index=25427, start_index=25336, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed')</li>
<li>AnnotationURLCitation(end_index=26253, start_index=26106, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=analysis%20showed%20that%20BICC1%20was,In%20cells%20and%20mice')</li>
<li>AnnotationURLCitation(end_index=26585, start_index=26454, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in')</li>
<li>AnnotationURLCitation(end_index=26750, start_index=26586, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=significance%20of%20BICC1%20in%20PAAD,levels%20had%20a%20significantly%20longer')</li>
<li>AnnotationURLCitation(end_index=27020, start_index=26873, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=analysis%20showed%20that%20BICC1%20was,In%20cells%20and%20mice')</li>
<li>AnnotationURLCitation(end_index=27152, start_index=27021, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in')</li>
<li>AnnotationURLCitation(end_index=27451, start_index=27320, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in')</li>
<li>AnnotationURLCitation(end_index=27602, start_index=27452, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L186%20overall%20survival,0.001%2C%20Fig.%201d%20and')</li>
<li>AnnotationURLCitation(end_index=28133, start_index=27958, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds')</li>
<li>AnnotationURLCitation(end_index=28299, start_index=28134, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=BICC1%20binds%20to%20the%203%E2%80%99UTR,factor%20CXCL1%2C%20leading%20to%20VEGF')</li>
<li>AnnotationURLCitation(end_index=28796, start_index=28621, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds')</li>
<li>AnnotationURLCitation(end_index=29107, start_index=28932, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds')</li>
<li>AnnotationURLCitation(end_index=29241, start_index=29108, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=29561, start_index=29428, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=29715, start_index=29562, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=effect%20of%20gemcitabine,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=30010, start_index=29877, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=30176, start_index=30011, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=BICC1%20binds%20to%20the%203%E2%80%99UTR,factor%20CXCL1%2C%20leading%20to%20VEGF')</li>
<li>AnnotationURLCitation(end_index=30387, start_index=30254, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=30555, start_index=30388, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=31008, start_index=30841, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=31157, start_index=31009, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=31471, start_index=31318, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=effect%20of%20gemcitabine,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=31620, start_index=31472, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=32221, start_index=32072, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found')</li>
<li>AnnotationURLCitation(end_index=32365, start_index=32222, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in')</li>
<li>AnnotationURLCitation(end_index=32734, start_index=32561, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1')</li>
<li>AnnotationURLCitation(end_index=32931, start_index=32735, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=expression%20and%20stromal%20score%20%28r%E2%80%89%3D%E2%80%890,cells%2C%20M0%20macrophage%2C%20M1%20macrophage')</li>
<li>AnnotationURLCitation(end_index=33315, start_index=33147, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Correlation%20between%20BICC1%20expression%20and,immune%20characteristics%20in%20PC')</li>
<li>AnnotationURLCitation(end_index=33447, start_index=33316, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Correlation%20of%20BICC1%20expression%20with,4')</li>
<li>AnnotationURLCitation(end_index=33830, start_index=33680, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=including%20age%2C%20gender%2C%20T%20stage%2C,009%29%2C%20and%20N')</li>
<li>AnnotationURLCitation(end_index=34152, start_index=34009, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in')</li>
<li>AnnotationURLCitation(end_index=34329, start_index=34153, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=furthermore%20confirm%20that%20BICC1%20influences,pathway%20to%20promote%20PC%20progression')</li>
<li>AnnotationURLCitation(end_index=34642, start_index=34474, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=match%20at%20L530%20mobilizing%20immune,future%20research%20in%20PC%20immunotherapy')</li>
<li>AnnotationURLCitation(end_index=35261, start_index=35099, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=Studies%20showed%20that%20BICC1%20is,revealed%20that%20BICC1%20promotes%20the')</li>
<li>AnnotationURLCitation(end_index=35561, start_index=35412, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found')</li>
<li>AnnotationURLCitation(end_index=35694, start_index=35562, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=match%20at%20L652%20BICC1%20as,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=35983, start_index=35834, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found')</li>
<li>AnnotationURLCitation(end_index=37014, start_index=36790, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=37382, start_index=37158, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=37746, start_index=37522, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=38112, start_index=37888, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=38525, start_index=38361, title='FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=cholangiocarcinoma%20who%20had%20FGFR2,is%20sensitive%20to%20sorafenib%20therapy')</li>
<li>AnnotationURLCitation(end_index=38693, start_index=38526, title='FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=no%20response%20and%20disease%20progression%2C,there%20were%20no%20adverse%20events')</li>
<li>AnnotationURLCitation(end_index=39050, start_index=38911, title='FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=sequencing%20,is%20sensitive%20to%20sorafenib%20therapy')</li>
<li>AnnotationURLCitation(end_index=39218, start_index=39051, title='FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6842751/#:~:text=no%20response%20and%20disease%20progression%2C,there%20were%20no%20adverse%20events')</li>
<li>AnnotationURLCitation(end_index=39740, start_index=39525, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=match%20at%20L579%20kinase%20that,new%20treatments%20for%20these%20cancers')</li>
<li>AnnotationURLCitation(end_index=40168, start_index=39944, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=40611, start_index=40418, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental')</li>
<li>AnnotationURLCitation(end_index=41119, start_index=40984, title='Role of the RNA-binding protein Bicaudal-C1 and interacting factors in cystic kidney diseases - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31838063/#:~:text=satellites%20that%20perturb%20complex%20protein,networks')</li>
<li>AnnotationURLCitation(end_index=41264, start_index=41120, title='Assessment of BicC family RNA binding protein 1 and Ras protein specific guanine nucleotide releasing factor 1 as candidate genes for high myopia: A case‚Äìcontrol study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5678326/#:~:text=Assessment%20of%20BicC%20family%20RNA,PMC%20Image%3A%20Close')</li>
<li>AnnotationURLCitation(end_index=41989, start_index=41825, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=example%2C%20mutations%20in%20BICC1%20lead,associated%20with%20PKD%20in%20vertebrates')</li>
<li>AnnotationURLCitation(end_index=42364, start_index=42233, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=miR,based%20translational%20control%20mechanism')</li>
<li>AnnotationURLCitation(end_index=42769, start_index=42556, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1')</li>
<li>AnnotationURLCitation(end_index=43134, start_index=42921, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=polycystic%20kidney%20disease%20,cognate%20microRNAs%20and%20the%20Bicc1')</li>
<li>AnnotationURLCitation(end_index=43350, start_index=43135, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=enzyme%20Dicer%20to%20mediate%20an,cognate%20microRNAs%20and%20the%20Bicc1')</li>
<li>AnnotationURLCitation(end_index=43974, start_index=43826, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018')</li>
<li>AnnotationURLCitation(end_index=44279, start_index=44131, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018')</li>
<li>AnnotationURLCitation(end_index=44624, start_index=44444, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=45238, start_index=45075, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L108%20recent%20years%2C,in%20oral%20cancer%2C%20promotes%20tumor')</li>
<li>AnnotationURLCitation(end_index=45567, start_index=45413, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=recent%20years%2C%20Bicaudal,in%20oral%20cancer%2C%20promotes%20tumor')</li>
<li>AnnotationURLCitation(end_index=45717, start_index=45568, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=and%20invasion%2C%20and%20correlates%20with,16%5D%20only%20found')</li>
<li>AnnotationURLCitation(end_index=46479, start_index=46346, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=46948, start_index=46811, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=development,provides%20an%20important%20step%20toward')</li>
<li>AnnotationURLCitation(end_index=47342, start_index=47220, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its')</li>
<li>AnnotationURLCitation(end_index=47464, start_index=47343, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=48328, start_index=48104, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=49445, start_index=49297, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=match%20at%20L600%20130,Structure%2026%2C%20209%E2%80%93224%20%282018')</li>
<li>AnnotationURLCitation(end_index=50010, start_index=49843, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L48%20VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=50159, start_index=50011, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=VEGF%20inhibitors,target%20for%20pancreatic%20cancer%20patients')</li>
<li>AnnotationURLCitation(end_index=50845, start_index=50723, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its')</li>
<li>AnnotationURLCitation(end_index=51166, start_index=50967, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,41%20Maerker%20et%20al')</li>
<li>AnnotationURLCitation(end_index=51511, start_index=51420, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed')</li>
<li>AnnotationURLCitation(end_index=51928, start_index=51778, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L186%20overall%20survival,0.001%2C%20Fig.%201d%20and')</li>
<li>AnnotationURLCitation(end_index=52278, start_index=52145, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=CXCL1,cancer%2C%20leading%20to%20resistance%20to')</li>
<li>AnnotationURLCitation(end_index=52444, start_index=52279, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=match%20at%20L134%20independent%20angiogenesis,for%20the%20treatment%20of%20PAAD')</li>
<li>AnnotationURLCitation(end_index=52810, start_index=52637, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1')</li>
<li>AnnotationURLCitation(end_index=53007, start_index=52811, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=expression%20and%20stromal%20score%20%28r%E2%80%89%3D%E2%80%890,cells%2C%20M0%20macrophage%2C%20M1%20macrophage')</li>
<li>AnnotationURLCitation(end_index=53278, start_index=53128, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=including%20age%2C%20gender%2C%20T%20stage%2C,009%29%2C%20and%20N')</li>
<li>AnnotationURLCitation(end_index=53617, start_index=53393, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
<li>AnnotationURLCitation(end_index=54986, start_index=54851, title='Role of the RNA-binding protein Bicaudal-C1 and interacting factors in cystic kidney diseases - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31838063/#:~:text=satellites%20that%20perturb%20complex%20protein,networks')</li>
<li>AnnotationURLCitation(end_index=55360, start_index=55232, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=kidney%20disease,383%2C%2016%E2%80%9321%20%282009')</li>
<li>AnnotationURLCitation(end_index=56034, start_index=55912, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=The%20RNA,of%20Pkd2%20mRNA%20and%20its')</li>
<li>AnnotationURLCitation(end_index=56181, start_index=56035, title='The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2835326/#:~:text=translation%20efficiency,Bicc1%20protein%20is%20localized%20to')</li>
<li>AnnotationURLCitation(end_index=56452, start_index=56361, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=,PubMed')</li>
<li>AnnotationURLCitation(end_index=56801, start_index=56649, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=binding%20sites%20are%20unknown,C%20target%20site%20was%20sufficient')</li>
<li>AnnotationURLCitation(end_index=56942, start_index=56802, title='Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3953263/#:~:text=This%2032,control%20cellular%20function%20in%20metazoans')</li>
<li>AnnotationURLCitation(end_index=57245, start_index=57124, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=Loss%20of%20the%20RNA,SAM%20interface')</li>
<li>AnnotationURLCitation(end_index=57426, start_index=57246, title='Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4561730/#:~:text=concentrates%20Bicc1%20in%20cytoplasmic%20clusters,mRNAs%20in%20specific%20silencing%20platforms')</li>
<li>AnnotationURLCitation(end_index=57871, start_index=57678, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=Bicaudal,organisms%20was%20the%20broad%20fundamental')</li>
<li>AnnotationURLCitation(end_index=58084, start_index=57872, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=In%20Xenopus%20embryos%2063%20Bicc1,mRNA%20network%20and%20provided%20a')</li>
<li>AnnotationURLCitation(end_index=58504, start_index=58329, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=with%20xenograft%20tumors%2C%20BICC1%20facilitated,level%20is%20elevated%2C%20LCN2%20binds')</li>
<li>AnnotationURLCitation(end_index=58636, start_index=58505, title='BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10344882/#:~:text=PAAD,role%20in%20Bevacizumab%20resistance%20in')</li>
<li>AnnotationURLCitation(end_index=59031, start_index=58858, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=We%20analyzed%20the%20correlation%20between,a%20positive%20correlation%20between%20BICC1')</li>
<li>AnnotationURLCitation(end_index=59175, start_index=59032, title='Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10601354/#:~:text=Using%20the%20CIBERSORT%20algorithm%2C%20the,cultured%20in')</li>
<li>AnnotationURLCitation(end_index=59539, start_index=59375, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=example%2C%20mutations%20in%20BICC1%20lead,associated%20with%20PKD%20in%20vertebrates')</li>
<li>AnnotationURLCitation(end_index=59654, start_index=59540, title='RNA-binding proteins and their role in kidney disease | Nature Reviews Nephrology', type='url_citation', url='https://www.nature.com/articles/s41581-021-00497-1#:~:text=133,33%2C%2086%E2%80%9390%20%282012')</li>
<li>AnnotationURLCitation(end_index=60105, start_index=59881, title='Frontiers | Bicaudal-C Post-transcriptional regulator of cell fates and functions', type='url_citation', url='https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.981696/full#:~:text=cholangiocarcinomas%20is%20a%20fusion%20between,The%20kinase%20portion%20of%20these')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9H694
gene_symbol: BICC1
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  BICC1 (BicC family RNA-binding protein 1) encodes an evolutionarily conserved
  RNA-binding protein that functions as a post-transcriptional regulator of gene
  expression. The protein contains three N-terminal KH (K Homology) domains that
  mediate RNA binding, and a C-terminal SAM (sterile alpha motif) domain that
  enables self-polymerization and protein-protein interactions. BICC1 acts primarily
  as a translational repressor, binding specific mRNA 3&#39;UTRs and recruiting the
  CCR4-NOT deadenylase complex or microRNA machinery to silence target transcripts.
  Key functions include negative regulation of the canonical Wnt signaling pathway
  and modulation of cAMP signaling through regulation of target mRNAs such as PKD2,
  ADCY6, and DVL2. BICC1 localizes to cytoplasmic P-bodies where it forms oligomeric
  silencing platforms. Loss of BICC1 function causes polycystic kidney disease in
  mice and humans, and mutations are associated with cystic renal dysplasia. BICC1
  is also involved in left-right axis determination during embryonic development.
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      BICC1 is well-established as a cytoplasmic protein. Studies show that
      endogenous BICC1 concentrates in discrete cytoplasmic foci that co-localize
      with P-body markers (GW182, HEDLS). The SAM domain drives self-polymerization
      leading to formation of cytoplasmic puncta (Rothe et al. 2015, PMC4561730).
    action: ACCEPT
    reason: &gt;-
      Strongly supported by multiple studies demonstrating BICC1 localizes to
      cytoplasmic P-bodies where it forms silencing platforms for mRNA regulation.
      UniProt also indicates cytoplasmic localization by similarity.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        BICC1 carries out its function in the cytoplasm, where it associates
        with macromolecular RNA-protein granules. Endogenous BICC1 protein
        concentrates in discrete cytoplasmic foci that co-localize with P-body
        markers (e.g. GW182 and HEDLS).
- term:
    id: GO:0003676
    label: nucleic acid binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      This annotation is too general. BICC1 specifically binds RNA, not DNA. The
      protein contains three KH domains that are classic RNA-binding motifs, and
      studies have identified specific RNA targets including a 32-nucleotide
      stem-loop structure in target mRNA 3&#39;UTRs (Zhang et al. 2014, PMC3953263).
    action: MODIFY
    reason: &gt;-
      While technically not wrong (RNA is a nucleic acid), this term is overly
      broad and does not capture the specific RNA-binding function of BICC1.
      The more specific term GO:0003723 (RNA binding) should be used.
    proposed_replacement_terms:
    - id: GO:0003723
      label: RNA binding
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        BICC1&#39;s three KH domains enable it to bind RNA with sequence/structure
        specificity. Canonical KH domains recognize short nucleotide motifs,
        often polypyrimidine tracts, but in BICC1 the recognition appears to
        involve RNA secondary structure.
- term:
    id: GO:0003723
    label: RNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      BICC1 is definitively an RNA-binding protein. It contains three KH domains
      that mediate RNA binding. Multiple studies have demonstrated direct RNA
      binding including identification of a 32-nt stem-loop binding element in
      the Cripto-1 3&#39;UTR (Zhang et al. 2014). RIP-seq in Xenopus identified 63
      direct mRNA targets.
    action: ACCEPT
    reason: &gt;-
      Core molecular function supported by extensive experimental evidence including
      biochemical studies (EMSA, RNase footprinting) and proteomics (interactome
      capture). The KH domains are well-characterized RNA-binding motifs.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Biochemical analyses (EMSA and footprinting) confirm that BICC1&#39;s N-terminal
        half (containing the KH/KHL domains) directly binds RNA hairpins - for
        instance, BICC1 protects the Cripto-1 3&#39;UTR stem-loop from RNase cleavage,
        highlighting a direct RNA-protein interaction.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      Duplicate annotation of cytoplasmic localization. This IEA annotation based
      on UniProt subcellular location is consistent with the IBA annotation and
      experimental evidence showing BICC1 in cytoplasmic P-bodies.
    action: ACCEPT
    reason: &gt;-
      Cytoplasmic localization is well-supported. While this duplicates the IBA
      annotation, both are accurate.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        BICC1 carries out its function in the cytoplasm, where it associates
        with macromolecular RNA-protein granules.
- term:
    id: GO:0006402
    label: mRNA catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      BICC1 participates in mRNA catabolism through recruitment of the CCR4-NOT
      deadenylase complex. In Drosophila, Bic-C physically associates with CCR4-NOT
      to deadenylate bound transcripts. This promotes mRNA poly(A) tail shortening
      which can lead to mRNA degradation (Rothe et al. 2015, PMC4561730).
    action: ACCEPT
    reason: &gt;-
      BICC1 recruits mRNA decay machinery to target transcripts. The CCR4-NOT
      deadenylase association is established and deadenylation is a key step in
      mRNA catabolism. However, note that BICC1&#39;s primary role may be translational
      repression rather than degradation per se.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Drosophila Bic-C physically associates with the CCR4-NOT deadenylase
        complex to deadenylate bound transcripts (including its own mRNA),
        indicating that BICC1 can induce mRNA poly(A) tail shortening to
        inhibit translation.
- term:
    id: GO:0006402
    label: mRNA catabolic process
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      Duplicate annotation of mRNA catabolic process. The ISS annotation from
      ortholog transfer is consistent with the IEA annotation and mechanistic
      evidence of CCR4-NOT deadenylase recruitment.
    action: ACCEPT
    reason: &gt;-
      Supported by evidence of BICC1 recruiting deadenylase machinery, though
      primary role is likely translational silencing with catabolism as a
      secondary outcome.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        BICC1 can recruit mRNA decay and translational inhibition machinery.
- term:
    id: GO:0007368
    label: determination of left/right symmetry
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      BICC1 is involved in left-right axis determination during embryonic
      development. Mouse Bicc1 knockout mutants exhibit visceral organs with
      random laterality due to disrupted embryonic node signaling. BICC1 binds
      and regulates Dand5 mRNA, an inhibitor of Nodal signaling crucial for
      left-right asymmetry (Rothe et al. 2015, PMC4561730; Dowdle et al. 2022).
    action: ACCEPT
    reason: &gt;-
      Well-supported by mouse knockout studies showing left-right patterning
      defects and identification of Dand5 as a BICC1 target mRNA critical for
      establishing asymmetry at the embryonic node.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Mouse Bicc1 knockout or spontaneous mutants (such as jcpk and bpk
        alleles) exhibit left-right patterning defects - the visceral organs
        show random laterality due to disrupted embryonic node signaling. This
        is attributed to misregulation of molecular cues at the embryonic node,
        where BICC1 is needed for planar cell polarity and proper orientation
        of motile cilia. Indeed, Bicc1 was recently shown to bind and regulate
        the mRNA of Dand5 (an inhibitor of Nodal signaling crucial for left-right
        asymmetry), linking BICC1 to left-right axis specification.
- term:
    id: GO:0003723
    label: RNA binding
  evidence_type: HDA
  original_reference_id: PMID:22658674
  review:
    summary: &gt;-
      BICC1 was identified as an mRNA-binding protein in the mRNA interactome
      capture study by Castello et al. 2012. This high-throughput UV crosslinking
      approach identified BICC1 among 860 proteins that qualify as RBPs by
      biochemical and statistical criteria in HeLa cells.
    action: ACCEPT
    reason: &gt;-
      The interactome capture methodology provides robust biochemical evidence
      for RNA binding. This complements the detailed mechanistic studies showing
      KH domain-mediated RNA binding.
    additional_reference_ids:
    - PMID:22658674
    supported_by:
    - reference_id: PMID:22658674
      supporting_text: &gt;-
        We identify 860 proteins that qualify as RBPs by biochemical and
        statistical criteria, adding more than 300 RBPs to those previously
        known and shedding light on RBPs in disease, RNA-binding enzymes of
        intermediary metabolism, RNA-binding kinases, and RNA-binding
        architectures.
- term:
    id: GO:0090090
    label: negative regulation of canonical Wnt signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:21922595
  review:
    summary: &gt;-
      BICC1 acts as a negative regulator of canonical Wnt signaling. Kraus et al.
      2012 demonstrated that human BICC1 blocks canonical Wnt signaling, similar
      to its mouse counterpart. Two patient mutations were characterized - a
      nonsense mutation in the KH domain caused complete loss of Wnt inhibitory
      activity, while a SAM domain mutation reduced activity by 22%. BICC1
      inhibits Dishevelled-2 (DVL2), a central Wnt signal transducer (Rothe et
      al. 2015, PMC4561730).
    action: ACCEPT
    reason: &gt;-
      Core function supported by direct experimental evidence in the cited paper.
      The mechanistic basis involves regulation of Dvl2 and potentially other
      Wnt pathway components. Loss of BICC1 causes ectopic Wnt/beta-catenin
      activity during development.
    additional_reference_ids:
    - PMID:21922595
    supported_by:
    - reference_id: PMID:21922595
      supporting_text: &gt;-
        In mice, Bicc1 blocks canonical Wnt signaling, mostly via its SAM
        domain. We show that the human BICC1, similar to its mouse counterpart,
        blocks canonical Wnt signaling. The nonsense mutation identified results
        in a complete loss of Wnt inhibitory activity. The point mutation in
        the SAM domain has a similar effect to a complete SAM domain deletion,
        resulting in a 22% loss of activity.
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        A study by Rothe et al. (2015) showed that BICC1 normally inhibits
        Dishevelled-2 (DVL2), a central Wnt signal transducer: BICC1 binds the
        Dvl2 mRNA or interacts with DVL2 protein complexes, and when BICC1
        polymerization is disrupted, DVL2 levels and Wnt activity rise
        abnormally.
- term:
    id: GO:0000956
    label: nuclear-transcribed mRNA catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      Proposed new annotation based on BICC1&#39;s role in mRNA regulation. BICC1
      recruits the CCR4-NOT deadenylase complex to target mRNAs, promoting their
      deadenylation and subsequent degradation. This specifically applies to
      nuclear-transcribed mRNAs.
    action: NEW
    reason: &gt;-
      While GO:0006402 (mRNA catabolic process) is already annotated, the more
      specific term for nuclear-transcribed mRNA catabolism may be appropriate
      given BICC1&#39;s targets are conventional mRNAs.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Drosophila Bic-C physically associates with the CCR4-NOT deadenylase
        complex to deadenylate bound transcripts.
- term:
    id: GO:0017148
    label: negative regulation of translation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      BICC1 functions as a translational repressor. It binds target mRNA 3&#39;UTRs
      and typically represses their translation through multiple mechanisms
      including deadenylation and recruitment of microRNA machinery. Validated
      targets include Cripto-1, Pkd2, and Wnt11b mRNAs (Zhang et al. 2014,
      PMC3953263; Dowdle et al. 2022).
    action: NEW
    reason: &gt;-
      This represents a core molecular function of BICC1 that is well-documented
      but not currently annotated. BICC1 acts as a translational repressor by
      binding 3&#39;UTRs and forming silencing complexes.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        BICC1 primarily acts as a post-transcriptional regulator of gene
        expression. It recognizes specific RNA sequences/structures in the
        3&#39; untranslated regions (3&#39;UTRs) of target mRNAs and typically
        represses their translation or reduces their stability.
- term:
    id: GO:0036464
    label: cytoplasmic ribonucleoprotein granule
  evidence_type: IDA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      BICC1 localizes to cytoplasmic P-bodies, which are ribonucleoprotein
      granules involved in mRNA storage, decay, and microRNA-mediated silencing.
      The SAM domain drives oligomerization and formation of these cytoplasmic
      puncta (Rothe et al. 2015, PMC4561730).
    action: NEW
    reason: &gt;-
      More specific cellular component than general cytoplasm. BICC1 specifically
      concentrates in P-bodies where it forms silencing platforms.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Endogenous BICC1 protein concentrates in discrete cytoplasmic foci
        that co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies
        are sites of mRNA storage, decay, and microRNA-mediated silencing,
        suggesting BICC1 functions within these structures to tether and
        regulate target mRNAs.
- term:
    id: GO:0000932
    label: P-body
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations.
    supported_by:
    - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
      supporting_text: &gt;-
        Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that
        co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites
        of mRNA storage, decay, and microRNA-mediated silencing.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with 
    GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to
    orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
    Location vocabulary mapping, accompanied by conservative changes to GO terms
    applied by UniProt
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data
    to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:21922595
  title: Two mutations in human BICC1 resulting in Wnt pathway hyperactivity 
    associated with cystic renal dysplasia.
  findings:
  - statement: &gt;-
      Human BICC1 blocks canonical Wnt signaling similar to mouse counterpart.
      Mutations in KH domain cause complete loss of Wnt inhibitory activity,
      while SAM domain mutations reduce activity by 22%.
    supporting_text: &gt;-
      In mice, Bicc1 blocks canonical Wnt signaling, mostly via its SAM domain.
      We show that the human BICC1, similar to its mouse counterpart, blocks
      canonical Wnt signaling. The nonsense mutation identified results in a
      complete loss of Wnt inhibitory activity. The point mutation in the SAM
      domain has a similar effect to a complete SAM domain deletion, resulting
      in a 22% loss of activity.
- id: PMID:22658674
  title: Insights into RNA biology from an atlas of mammalian mRNA-binding 
    proteins.
  findings:
  - statement: &gt;-
      BICC1 identified as RNA-binding protein through interactome capture in
      HeLa cells using UV crosslinking methodology.
    supporting_text: &gt;-
      We identify 860 proteins that qualify as RBPs by biochemical and
      statistical criteria, adding more than 300 RBPs to those previously
      known and shedding light on RBPs in disease, RNA-binding enzymes of
      intermediary metabolism, RNA-binding kinases, and RNA-binding
      architectures.
- id: file:human/BICC1/BICC1-deep-research-openai.md
  title: Deep research on BICC1 gene function (OpenAI o3-deep-research, January 
    2026)
  findings:
  - statement: &gt;-
      BICC1 is an RNA-binding protein that acts as a translational repressor,
      binding specific mRNA 3&#39;UTRs via KH domains and recruiting silencing
      machinery including the CCR4-NOT deadenylase complex.
    supporting_text: &gt;-
      BICC1 primarily acts as a post-transcriptional regulator of gene expression.
      It recognizes specific RNA sequences/structures in the 3&#39; untranslated
      regions (3&#39;UTRs) of target mRNAs and typically represses their translation
      or reduces their stability.
  - statement: &gt;-
      BICC1 localizes to cytoplasmic P-bodies where it forms oligomeric silencing
      platforms through SAM domain-mediated self-polymerization.
    supporting_text: &gt;-
      Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that
      co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites
      of mRNA storage, decay, and microRNA-mediated silencing.
  - statement: &gt;-
      BICC1 negatively regulates canonical Wnt signaling by inhibiting Dishevelled-2
      (DVL2). Loss of BICC1 causes ectopic Wnt/beta-catenin activity during
      embryonic development.
    supporting_text: &gt;-
      A study by Rothe et al. (2015) showed that BICC1 normally inhibits
      Dishevelled-2 (DVL2), a central Wnt signal transducer: BICC1 binds the
      Dvl2 mRNA or interacts with DVL2 protein complexes, and when BICC1
      polymerization is disrupted, DVL2 levels and Wnt activity rise abnormally.
  - statement: &gt;-
      BICC1 is essential for kidney development and homeostasis. Loss of BICC1
      causes polycystic kidney disease in mice and humans through dysregulation
      of PKD2 and cAMP signaling.
    supporting_text: &gt;-
      BICC1 safeguards kidney tubule morphology by regulating specific mRNAs
      tied to epithelial differentiation and signaling. A key target is PKD2
      (Polycystin-2), a Ca2+-permeable channel essential for renal tubule
      integrity. Wessely and colleagues (2010) discovered that BICC1 binds to
      and stabilizes Pkd2 mRNA, enhancing Polycystin-2 expression.
  - statement: &gt;-
      Mouse Bicc1 knockout mutants exhibit left-right patterning defects due to
      misregulation of Dand5 mRNA at the embryonic node.
    supporting_text: &gt;-
      Mouse Bicc1 knockout or spontaneous mutants (such as jcpk and bpk alleles)
      exhibit left-right patterning defects - the visceral organs show random
      laterality due to disrupted embryonic node signaling.
core_functions:
- molecular_function:
    id: GO:0003723
    label: RNA binding
  directly_involved_in:
  - id: GO:0017148
    label: negative regulation of translation
  - id: GO:0090090
    label: negative regulation of canonical Wnt signaling pathway
  locations:
  - id: GO:0005737
    label: cytoplasm
  - id: GO:0000932
    label: P-body
  description: &gt;-
    BICC1 functions as an RNA-binding translational repressor. It contains three
    KH domains that bind specific stem-loop structures in target mRNA 3&#39;UTRs,
    including Cripto-1, Pkd2, Dvl2, Wnt11b, and Dand5. BICC1 recruits the CCR4-NOT
    deadenylase complex to silence target transcripts. The SAM domain mediates
    self-polymerization and localization to cytoplasmic P-bodies where BICC1 forms
    oligomeric silencing platforms. Through regulation of Dvl2 and other Wnt pathway
    components, BICC1 negatively regulates canonical Wnt signaling. Evidence includes
    mRNA interactome capture (PMID:22658674), functional studies showing Wnt pathway
    regulation (PMID:21922595), and biochemical characterization of RNA binding
    (Zhang et al. 2014, PMC3953263).
  supported_by:
  - reference_id: file:human/BICC1/BICC1-deep-research-openai.md
    supporting_text: &gt;-
      Endogenous BICC1 protein concentrates in discrete cytoplasmic foci that
      co-localize with P-body markers (e.g. GW182 and HEDLS). P-bodies are sites
      of mRNA storage, decay, and microRNA-mediated silencing.
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>